9th Impurities Summit

Share this event:
4061996
DD
Days
HH
Hours
MM
Min
SS
Sec

Start Date

April 9

End Date

April 10

City

Vienna

9th Impurities: Genotoxic, Nitrosamine, & Beyond Summit

Join us in Vienna or Online : 9 – 10 April 2025

 

The detection and control of nitrosamines and other genotoxic impurities (GTIs) have become critical concerns, necessitating a comprehensive and rational risk assessment strategy to ensure product safety and regulatory compliance.

Welcome to #VLgenotoxic 2025, where our focus intensifies on the urgent issues surrounding N-nitrosamines. As the industry grapples with evolving regulatory frameworks, toxicological uncertainties, and the technical challenges of impurity identification, this summit serves as a vital platform for exploring these pressing issues.

Venue Details

Novotel Wien Hauptbahnhof, Canettistraße 6, 1100 Wien, Austria
Vienna, Austria

Events Details

Time :
All day
Categories :

Add to Calendar

+ Google Calendar
+ ICal Export
+ Outlook

More Events

EIP

February 24 - February 26

SOT

March 16 - March 20

WRIB

April 7 - April 11

Visit our Events page

Visit Events

Get our latest updates straight to your inbox

About

Linkedin

Support

Copyright © 2024 Resolian Inc. All rights reserved.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.